{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:13:18Z","timestamp":1785510798012,"version":"3.56.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05299-7","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:53:40Z","timestamp":1785509620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psoriasis and chronic kidney disease: insights into mechanisms and novel therapeutic outlooks"],"prefix":"10.1007","author":[{"given":"Tailai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"issue":"1","key":"5299_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.pcl.2018.09.007","volume":"66","author":"OM Akchurin","year":"2019","unstructured":"Akchurin OM (2019) Chronic kidney disease and dietary measures to improve outcomes. Pediatr Clin N Am 66(1):247\u2013267. https:\/\/doi.org\/10.1016\/j.pcl.2018.09.007","journal-title":"Pediatr Clin N Am"},{"issue":"3","key":"5299_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-064540","volume":"13","author":"X Feng","year":"2023","unstructured":"Feng X, Hou N, Chen Z, Liu J, Li X, Sun X, Liu Y (2023) Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the Global Burden of Disease Study 2019. BMJ Open 13(3):e064540. https:\/\/doi.org\/10.1136\/bmjopen-2022-064540","journal-title":"BMJ Open"},{"issue":"13","key":"5299_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296\u20131305. https:\/\/doi.org\/10.1056\/NEJMoa041031","journal-title":"N Engl J Med"},{"issue":"10302","key":"5299_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/s0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V (2021) Chronic kidney disease. Lancet 398(10302):786\u2013802. https:\/\/doi.org\/10.1016\/s0140-6736(21)00519-5","journal-title":"Lancet"},{"issue":"1","key":"5299_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2012.64","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) Chapter 1: definition and classification of CKD. Kidney Int Suppl (2011) 3(1):19\u201362. https:\/\/doi.org\/10.1038\/kisup.2012.64","journal-title":"Kidney Int Suppl (2011)"},{"issue":"Suppl 1","key":"5299_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1755-6686.2009.00062.x","volume":"35","author":"C Limrick","year":"2009","unstructured":"Limrick C, McNichols-Thomas C (2009) Anaemia and mineral bone disorder in chronic kidney disease: a review of the current literature and implications for clinical nursing practice. J Ren Care 35(Suppl 1):94\u2013100. https:\/\/doi.org\/10.1111\/j.1755-6686.2009.00062.x","journal-title":"J Ren Care"},{"issue":"10075","key":"5299_CR7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/s0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P (2017) Chronic kidney disease. Lancet 389(10075):1238\u20131252. https:\/\/doi.org\/10.1016\/s0140-6736(16)32064-5","journal-title":"Lancet"},{"issue":"3","key":"5299_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/ncpneph1040","volume":"5","author":"DR Kuypers","year":"2009","unstructured":"Kuypers DR (2009) Skin problems in chronic kidney disease. Nat Clin Pract Nephrol 5(3):157\u2013170. https:\/\/doi.org\/10.1038\/ncpneph1040","journal-title":"Nat Clin Pract Nephrol"},{"issue":"5","key":"5299_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/ddg.14087","volume":"18","author":"A Conti","year":"2020","unstructured":"Conti A, Giovannini L, Mandel VD, Odorici G, Lasagni C, Bigi L, Pellacani G, Cappelli G (2020) Chronic kidney disease in psoriasis: a cohort study. J Dtsch Dermatol Ges 18(5):438\u2013445. https:\/\/doi.org\/10.1111\/ddg.14087","journal-title":"J Dtsch Dermatol Ges"},{"issue":"10225","key":"5299_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration (2020) Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395(10225):709\u2013733. https:\/\/doi.org\/10.1016\/s0140-6736(20)30045-3","journal-title":"Lancet"},{"issue":"04","key":"5299_CR11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.47191\/ijmscrs\/v4-i04-25","volume":"4","author":"C Daniela Guerrero","year":"2024","unstructured":"Daniela Guerrero C (2024) Psoriasis. Definition and classification of a complex entity. Int J Med Sci Clin Res Stud 4(04):748\u2013752. https:\/\/doi.org\/10.47191\/ijmscrs\/v4-i04-25","journal-title":"Int J Med Sci Clin Res Stud"},{"key":"5299_CR12","doi-asserted-by":"publisher","DOI":"10.58806\/ijhmr.2024.v3i08n13","author":"M Adil","year":"2024","unstructured":"Adil M, Alfahham AA, Alhusseini NB (2024) The epidemiology, etiology, and therapeutic approaches of psoriasis: a review article. Int J Health Med Res. https:\/\/doi.org\/10.58806\/ijhmr.2024.v3i08n13","journal-title":"Int J Health Med Res"},{"key":"5299_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16010111","author":"A Drakos","year":"2024","unstructured":"Drakos A, Torres T, Vender R (2024) Emerging oral therapies for the treatment of psoriasis: a review of pipeline agents. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics16010111","journal-title":"Pharmaceutics"},{"key":"5299_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207488","author":"M Tokuyama","year":"2020","unstructured":"Tokuyama M, Mabuchi T (2020) New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21207488","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5299_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/1346-8138.14338","volume":"45","author":"S Imafuku","year":"2018","unstructured":"Imafuku S, Zheng M, Tada Y, Zhang X, Theng C, Thevarajah S, Zhao Y, Song HJ (2018) Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy. J Dermatol 45(7):805\u2013811. https:\/\/doi.org\/10.1111\/1346-8138.14338","journal-title":"J Dermatol"},{"key":"5299_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.12703\/p6-4","volume":"6","author":"K Belge","year":"2014","unstructured":"Belge K, Br\u00fcck J, Ghoreschi K (2014) Advances in treating psoriasis. F1000Prime Rep 6:4. https:\/\/doi.org\/10.12703\/p6-4","journal-title":"F1000Prime Rep"},{"key":"5299_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/btt.S41481","volume":"8","author":"D Kivelevitch","year":"2014","unstructured":"Kivelevitch D, Mansouri B, Menter A (2014) Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis. Biologics 8:169\u2013182. https:\/\/doi.org\/10.2147\/btt.S41481","journal-title":"Biologics"},{"issue":"3","key":"5299_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0163-8343(87)90001-6","volume":"9","author":"MA Gupta","year":"1987","unstructured":"Gupta MA, Gupta AK, Haberman HF (1987) Psoriasis and psychiatry: an update. Gen Hosp Psychiatry 9(3):157\u2013166. https:\/\/doi.org\/10.1016\/0163-8343(87)90001-6","journal-title":"Gen Hosp Psychiatry"},{"key":"5299_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713313","author":"HJ Lee","year":"2023","unstructured":"Lee HJ, Kim M (2023) Challenges and future trends in the treatment of psoriasis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241713313","journal-title":"Int J Mol Sci"},{"key":"5299_CR20","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.2147\/ccid.S420900","volume":"16","author":"J Xu","year":"2023","unstructured":"Xu J, Chen A, Peng Y, Wen Z, Huang K, Wang P (2023) A case report of adalimumab successfully treated a severe plaque psoriasis patient with psoriatic end-stage renal disease. Clin Cosmet Investig Dermatol 16:2841\u20132846. https:\/\/doi.org\/10.2147\/ccid.S420900","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"8","key":"5299_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237816","volume":"15","author":"KL Liu","year":"2020","unstructured":"Liu KL, Tsai WC, Tu HP, Lee CH (2020) Statin use and the risk of chronic kidney disease in patients with psoriasis: a nationwide cohort study in Taiwan. PLoS ONE 15(8):e0237816. https:\/\/doi.org\/10.1371\/journal.pone.0237816","journal-title":"PLoS ONE"},{"issue":"2","key":"5299_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.25259\/ijdvl_372_19","volume":"87","author":"M Munera-Campos","year":"2021","unstructured":"Munera-Campos M, Ferr\u00e1ndiz C, Mateo L, Prior-Espa\u00f1ol \u00c1, Carrascosa JM (2021) Prevalence and stages of chronic kidney disease in psoriasis and psoriatic arthritis: a cross-sectional study. Indian J Dermatol Venereol Leprol 87(2):321. https:\/\/doi.org\/10.25259\/ijdvl_372_19","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"5299_CR23","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2025.10083","author":"MT Alrubaiaan","year":"2025","unstructured":"Alrubaiaan MT, Alhobabi AD, Alharthi RM, Alsulaiman SA, Altasan AN, Momen IM, Almohideb M (2025) Prevalence and association of renal disorders in Saudi adult patients with psoriasis and psoriatic arthritis: a tertiary-center retrospective cross-sectional study. Dermatol Reports. https:\/\/doi.org\/10.4081\/dr.2025.10083","journal-title":"Dermatol Reports"},{"key":"5299_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59024-0","author":"E Lee","year":"2020","unstructured":"Lee E, Han JH, Bang CH, Yoo SA, Han KD, Kim H-N, Park YM, Lee JY, Lee JH (2020) Risk of end-stage renal disease in psoriatic patients: real-world data from a nationwide population-based cohort study (vol 10, 2284, 2019). Sci Rep. https:\/\/doi.org\/10.1038\/s41598-020-59024-0","journal-title":"Sci Rep"},{"issue":"9","key":"5299_CR25","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/1346-8138.14531","volume":"45","author":"CC Wang","year":"2018","unstructured":"Wang CC, Tang CH, Huang KC, Huang SY, Sue YM (2018) Increased risk of incident psoriasis in end-stage renal disease patients on chronic hemodialysis: a nationwide population-based cohort study. J Dermatol 45(9):1063\u20131070. https:\/\/doi.org\/10.1111\/1346-8138.14531","journal-title":"J Dermatol"},{"issue":"5","key":"5299_CR26","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1159\/000522228","volume":"238","author":"R Friedland","year":"2022","unstructured":"Friedland R, Kridin K, Cohen AD, Landau D, Ben-Amitai D (2022) Psoriasis and renal disorders: a large-scale population-based study in children and adults. Dermatology 238(5):904\u2013909. https:\/\/doi.org\/10.1159\/000522228","journal-title":"Dermatology"},{"issue":"11","key":"5299_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/nep.14220","volume":"28","author":"S Yin","year":"2023","unstructured":"Yin S, Zhou Z, Wu J, Wang X, Lin T (2023) Psoriasis and risk of chronic kidney diseases: a population-based cross-sectional study and Mendelian randomization analysis. Nephrology (Carlton) 28(11):611\u2013619. https:\/\/doi.org\/10.1111\/nep.14220","journal-title":"Nephrology (Carlton)"},{"key":"5299_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010249","author":"Y Tan","year":"2024","unstructured":"Tan Y, Huang Z, Li H, Yao H, Fu Y, Wu X, Lin C, Lai Z, Yang G, Jing C (2024) Association between psoriasis and renal functions: an integration study of observational study and Mendelian randomization. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12010249","journal-title":"Biomedicines"},{"key":"5299_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154328","author":"J Wild","year":"2022","unstructured":"Wild J, Keller K, Karbach S, Weinmann-Menke J, M\u00fcnzel T, Hobohm L (2022) Case-fatality and temporal trends in patients with psoriasis and end-stage renal disease. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11154328","journal-title":"J Clin Med"},{"issue":"9811","key":"5299_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/s0140-6736(11)60178-5","volume":"379","author":"AS Levey","year":"2012","unstructured":"Levey AS, Coresh J (2012) Chronic kidney disease. Lancet 379(9811):165\u2013180. https:\/\/doi.org\/10.1016\/s0140-6736(11)60178-5","journal-title":"Lancet"},{"issue":"1","key":"5299_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.amjms.2021.03.009","volume":"362","author":"MJ Schwade","year":"2021","unstructured":"Schwade MJ, Tien L, Waller JL, Davis LS, Baer SL, Mohammed A, Young L, Kheda MF, Bollag WB (2021) Treatment of psoriasis in end-stage renal disease patients is associated with decreased mortality: a retrospective cohort study. Am J Med Sci 362(1):24\u201333. https:\/\/doi.org\/10.1016\/j.amjms.2021.03.009","journal-title":"Am J Med Sci"},{"issue":"7","key":"5299_CR32","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1016\/j.transproceed.2013.08.005","volume":"45","author":"C Mele","year":"2013","unstructured":"Mele C, Salerno MP, Romagnoli J, De Simone C, Castriota M, Citterio F (2013) Complete clinical remission of psoriasis 6 months after renal transplantation. Transplant Proc 45(7):2788\u20132789. https:\/\/doi.org\/10.1016\/j.transproceed.2013.08.005","journal-title":"Transplant Proc"},{"key":"5299_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/ccid.S499202","volume":"18","author":"T Yin","year":"2025","unstructured":"Yin T, Zhang T, Ma L (2025) A novel immune-related three-gene signature and immune infiltration insights in psoriasis and chronic kidney disease. Clin Cosmet Investig Dermatol 18:267\u2013286. https:\/\/doi.org\/10.2147\/ccid.S499202","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"5299_CR34","doi-asserted-by":"publisher","first-page":"1175477","DOI":"10.3389\/fmed.2023.1175477","volume":"10","author":"X Jing","year":"2023","unstructured":"Jing X, Zhuyuan W, Aijun C, Jianxia X, Kun H, Ping W (2023) Association of psoriasis with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis. Front Med (Lausanne) 10:1175477. https:\/\/doi.org\/10.3389\/fmed.2023.1175477","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"5299_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/path.5508","volume":"252","author":"S Li","year":"2020","unstructured":"Li S, Liu Y, He Y, Rong W, Zhang M, Li L, Liu Z, Zen K (2020) Podocytes present antigen to activate specific T cell immune responses in inflammatory renal disease. J Pathol 252(2):165\u2013177. https:\/\/doi.org\/10.1002\/path.5508","journal-title":"J Pathol"},{"issue":"2","key":"5299_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.imlet.2011.10.002","volume":"141","author":"BH Chung","year":"2012","unstructured":"Chung BH, Kim KW, Sun IO, Choi SR, Park HS, Jeon EJ, Kim B-M, Choi BS, Park CW, Kim Y-S, Cho M-L, Yang CW (2012) Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients. Immunol Lett 141(2):181\u2013189. https:\/\/doi.org\/10.1016\/j.imlet.2011.10.002","journal-title":"Immunol Lett"},{"issue":"1","key":"5299_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bjd.19380","volume":"184","author":"L Nussbaum","year":"2020","unstructured":"Nussbaum L, Chen YL, Ogg GS (2020) Role of regulatory T cells in psoriasis pathogenesis and treatment. Br J Dermatol 184(1):14\u201324. https:\/\/doi.org\/10.1111\/bjd.19380","journal-title":"Br J Dermatol"},{"key":"5299_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01546","author":"S Dellepiane","year":"2020","unstructured":"Dellepiane S, Leventhal JS, Cravedi P (2020) T cells and acute kidney injury: a two-way relationship. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.01546","journal-title":"Front Immunol"},{"key":"5299_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3535264","volume":"2020","author":"F Ren","year":"2020","unstructured":"Ren F, Zhang M, Zhang C, Sang H (2020) Psoriasis-like inflammation induced renal dysfunction through the TLR\/NF-\u03baB signal pathway. BioMed Res Int 2020:3535264. https:\/\/doi.org\/10.1155\/2020\/3535264","journal-title":"BioMed Res Int"},{"issue":"10","key":"5299_CR40","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30061","volume":"14","author":"P Pandey","year":"2022","unstructured":"Pandey P, Kumar S (2022) Effectiveness of dialysis in psoriasis: a short review. Cureus 14(10):e30061. https:\/\/doi.org\/10.7759\/cureus.30061","journal-title":"Cureus"},{"issue":"5","key":"5299_CR41","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/bjd.14961","volume":"176","author":"SK Grewal","year":"2017","unstructured":"Grewal SK, Wan J, Denburg MR, Shin DB, Takeshita J, Gelfand JM (2017) The risk of IgA nephropathy and glomerular disease in patients with psoriasis: a population-based cohort study. Br J Dermatol 176(5):1366\u20131369. https:\/\/doi.org\/10.1111\/bjd.14961","journal-title":"Br J Dermatol"},{"key":"5299_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/jci39189","author":"RJ Glassock","year":"2009","unstructured":"Glassock RJ (2009) Analyzing antibody activity in IgA nephropathy. J Clin Invest. https:\/\/doi.org\/10.1172\/jci39189","journal-title":"J Clin Invest"},{"issue":"5","key":"5299_CR43","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1159\/000013388","volume":"18","author":"TS Ahuja","year":"1998","unstructured":"Ahuja TS, Funtanilla M, de Groot JJ, Velasco A, Badalamenti J, Wilson S (1998) IgA nephropathy in psoriasis. Am J Nephrol 18(5):425\u2013429. https:\/\/doi.org\/10.1159\/000013388","journal-title":"Am J Nephrol"},{"issue":"3","key":"5299_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/joneph\/19.3.382","volume":"19","author":"J Zadrazil","year":"2006","unstructured":"Zadrazil J, Tich\u00fd T, Hor\u00e1k P, Nikorjakov\u00e1 I, Z\u00edma P, Krejc\u00ed K, Str\u00e9bl P (2006) IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of \u2018psoriatic nephropathy.\u2019 J Nephrol 19(3):382\u2013386","journal-title":"J Nephrol"},{"issue":"2","key":"5299_CR45","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1111\/ijd.16903","volume":"63","author":"S Kulakl\u0131","year":"2024","unstructured":"Kulakl\u0131 S, Akag\u00fcn T (2024) A case of psoriasis with IgA nephropathy successfully treated with secukinumab. Int J Dermatol 63(2):e35\u2013e37. https:\/\/doi.org\/10.1111\/ijd.16903","journal-title":"Int J Dermatol"},{"issue":"1","key":"5299_CR46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10238-025-01750-8","volume":"25","author":"D He","year":"2025","unstructured":"He D, Bi G, Mou H, Wang R, Lu C, Tang Z (2025) Clinicopathological features and renal outcomes in patients with IgA nephropathy secondary to psoriasis. Clin Exp Med 25(1):207. https:\/\/doi.org\/10.1007\/s10238-025-01750-8","journal-title":"Clin Exp Med"},{"issue":"2","key":"5299_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","volume":"361","author":"A Rajasekaran","year":"2021","unstructured":"Rajasekaran A, Julian BA, Rizk DV (2021) IgA nephropathy: an interesting autoimmune kidney disease. Am J Med Sci 361(2):176\u2013194. https:\/\/doi.org\/10.1016\/j.amjms.2020.10.003","journal-title":"Am J Med Sci"},{"issue":"7","key":"5299_CR48","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s11255-018-1868-z","volume":"50","author":"P Ungprasert","year":"2018","unstructured":"Ungprasert P, Raksasuk S (2018) Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 50(7):1277\u20131283. https:\/\/doi.org\/10.1007\/s11255-018-1868-z","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"5299_CR49","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1093\/ndt\/gfs438","volume":"27","author":"A Ozyilmaz","year":"2012","unstructured":"Ozyilmaz A, de Jong PE, Gansevoort RT (2012) Screening for chronic kidney disease can be of help to prevent atherosclerotic end organ damage. Nephrol Dial Transplant 27(11):4046\u20134052. https:\/\/doi.org\/10.1093\/ndt\/gfs438","journal-title":"Nephrol Dial Transplant"},{"issue":"6917","key":"5299_CR50","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868\u2013874. https:\/\/doi.org\/10.1038\/nature01323","journal-title":"Nature"},{"issue":"6","key":"5299_CR51","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.mcna.2015.08.001","volume":"99","author":"KT Shahwan","year":"2015","unstructured":"Shahwan KT, Kimball AB (2015) Psoriasis and cardiovascular disease. Med Clin N Am 99(6):1227\u20131242. https:\/\/doi.org\/10.1016\/j.mcna.2015.08.001","journal-title":"Med Clin N Am"},{"issue":"2","key":"5299_CR52","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cmet.2018.10.006","volume":"29","author":"L-H Huang","year":"2019","unstructured":"Huang L-H, Zinselmeyer BH, Chang C-H, Saunders BT, Elvington A, Baba O, Broekelmann TJ, Qi L, Rueve JS, Swartz MA, Kim BS, Mecham RP, Wiig H, Thomas MJ, Sorci-Thomas MG, Randolph GJ (2019) Interleukin-17 drives interstitial entrapment of tissue lipoproteins in experimental psoriasis. Cell Metab 29(2):475-487.e477. https:\/\/doi.org\/10.1016\/j.cmet.2018.10.006","journal-title":"Cell Metab"},{"issue":"4","key":"5299_CR53","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/atvbaha.118.312246","volume":"39","author":"MS Garshick","year":"2019","unstructured":"Garshick MS, Barrett TJ, Wechter T, Azarchi S, Scher JU, Neimann A, Katz S, Fuentes-Duculan J, Cannizzaro MV, Jelic S, Fisher EA, Krueger JG, Berger JS (2019) Inflammasome signaling and impaired vascular health in psoriasis. Arterioscler Thromb Vasc Biol 39(4):787\u2013798. https:\/\/doi.org\/10.1161\/atvbaha.118.312246","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"5299_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/ijd.16343","volume":"62","author":"HAS Bazid","year":"2023","unstructured":"Bazid HAS, Shoeib MA, El-Sayed S, Mostafa MI, Shoeib MM, Eldeen ES (2023) Study of purine derivatives and their relation to renal disorders in patients with psoriasis. Int J Dermatol 62(1):73\u201378. https:\/\/doi.org\/10.1111\/ijd.16343","journal-title":"Int J Dermatol"},{"key":"5299_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9080752","author":"A Podkowi\u0144ska","year":"2020","unstructured":"Podkowi\u0144ska A, Formanowicz D (2020) Chronic kidney disease as oxidative stress- and inflammatory-mediated cardiovascular disease. Antioxidants. https:\/\/doi.org\/10.3390\/antiox9080752","journal-title":"Antioxidants"},{"key":"5299_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2017.02.018","volume":"46","author":"NO Al-Harbi","year":"2017","unstructured":"Al-Harbi NO, Nadeem A, Ansari MA, Al-Harbi MM, Alotaibi MR, AlSaad AM, Ahmad SF (2017) Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase. Int Immunopharmacol 46:1\u20138. https:\/\/doi.org\/10.1016\/j.intimp.2017.02.018","journal-title":"Int Immunopharmacol"},{"key":"5299_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.03.098","author":"T Sontam","year":"2025","unstructured":"Sontam T, Cho SW, Chen A, Chen H, Raman J, Tarbox M (2025) Psoriasis is associated with an increased risk of chronic kidney disease in diabetic patients despite renoprotective or biologic therapy: a retrospective cohort study. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2025.03.098","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"5299_CR58","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/archderm.138.6.791","volume":"138","author":"D Creamer","year":"2002","unstructured":"Creamer D, Allen M, Jaggar R, Stevens R, Bicknell R, Barker J (2002) Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor. Arch Dermatol 138(6):791\u2013796. https:\/\/doi.org\/10.1001\/archderm.138.6.791","journal-title":"Arch Dermatol"},{"key":"5299_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153711","author":"A Duni","year":"2019","unstructured":"Duni A, Liakopoulos V, Roumeliotis S, Peschos D, Dounousi E (2019) Oxidative stress in the pathogenesis and evolution of chronic kidney disease: untangling Ariadne\u2019s thread. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20153711","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5299_CR60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.25259\/ijdvl_669_2023","volume":"91","author":"SA Yoo","year":"2025","unstructured":"Yoo SA, Sayo MIA, Lee JH (2025) Association between chronic renal disease and psoriasis risk in diabetes patients: a Korean population-based study. Indian J Dermatol Venereol Leprol 91(2):152\u2013157. https:\/\/doi.org\/10.25259\/ijdvl_669_2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"5299_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"S-H Lee","year":"2022","unstructured":"Lee S-H, Park S-Y, Choi CS (2022) Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J 46(1):15\u201337. https:\/\/doi.org\/10.4093\/dmj.2021.0280","journal-title":"Diabetes Metab J"},{"key":"5299_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR (2021) Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. https:\/\/doi.org\/10.1016\/j.metabol.2021.154766","journal-title":"Metabolism"},{"key":"5299_CR63","doi-asserted-by":"publisher","first-page":"6613827","DOI":"10.1155\/2021\/6613827","volume":"2021","author":"M Maru\u0161i\u0107","year":"2021","unstructured":"Maru\u0161i\u0107 M, Pai\u0107 M, Knobloch M, LiberatiPr\u0161o AM (2021) NAFLD, insulin resistance, and diabetes mellitus type 2. Can J Gastroenterol Hepatol 2021:6613827. https:\/\/doi.org\/10.1155\/2021\/6613827","journal-title":"Can J Gastroenterol Hepatol"},{"key":"5299_CR64","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.2147\/dmso.S273147","volume":"13","author":"R Abramczyk","year":"2020","unstructured":"Abramczyk R, Queller JN, Rachfal AW, Schwartz SS (2020) Diabetes and psoriasis: different sides of the same prism. Diabetes Metab Syndr Obes 13:3571\u20133577. https:\/\/doi.org\/10.2147\/dmso.S273147","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"12","key":"5299_CR65","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s11255-018-1934-6","volume":"50","author":"A Ma","year":"2018","unstructured":"Ma A, Liu F, Wang C, Liang K, Yan F, Hou X, Liu J, Chen L (2018) Both insulin resistance and metabolic syndrome accelerate the progression of chronic kidney disease among Chinese adults: results from a 3-year follow-up study. Int Urol Nephrol 50(12):2239\u20132244. https:\/\/doi.org\/10.1007\/s11255-018-1934-6","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"5299_CR66","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1152\/physrev.00036.2005","volume":"86","author":"M Paul","year":"2006","unstructured":"Paul M, Poyan Mehr A, Kreutz R (2006) Physiology of local renin-angiotensin systems. Physiol Rev 86(3):747\u2013803. https:\/\/doi.org\/10.1152\/physrev.00036.2005","journal-title":"Physiol Rev"},{"issue":"3","key":"5299_CR67","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","volume":"98","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, Scalia R, Eguchi S (2018) Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev 98(3):1627\u20131738. https:\/\/doi.org\/10.1152\/physrev.00038.2017","journal-title":"Physiol Rev"},{"key":"5299_CR68","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2147\/ccid.S212781","volume":"12","author":"MI ElGhareeb","year":"2019","unstructured":"ElGhareeb MI, Khater MH, Fakhr A, Khedr HA (2019) Risk and severity of psoriasis vulgaris in relation to angiotensin II type 1 receptor gene polymorphism and metabolic syndrome. Clin Cosmet Investig Dermatol 12:683\u2013690. https:\/\/doi.org\/10.2147\/ccid.S212781","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"5299_CR69","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1053\/j.ajkd.2018.06.016","volume":"73","author":"L Koppe","year":"2019","unstructured":"Koppe L, Fouque D (2019) The role for protein restriction in addition to renin-angiotensin-aldosterone system inhibitors in the management of CKD. Am J Kidney Dis 73(2):248\u2013257. https:\/\/doi.org\/10.1053\/j.ajkd.2018.06.016","journal-title":"Am J Kidney Dis"},{"issue":"20","key":"5299_CR70","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/cir.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, Despres J-P, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekavich CL, Lewis EF, Lo KB, Ozkan B, Palaniappan LP, Patel SS, Pencina MJ, Powell-Wiley TM, Sperling LS, Virani SS, Wright JT, Rajgopal Singh R, Elkind MSV (2023) Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation 148(20):1606\u20131635. https:\/\/doi.org\/10.1161\/cir.0000000000001184","journal-title":"Circulation"},{"issue":"6","key":"5299_CR71","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.amjms.2023.09.014","volume":"366","author":"N Siddiquee","year":"2023","unstructured":"Siddiquee N, Waller JL, Baer SL, Mohammed A, Tran S, Padala S, Young L, Kheda M, Bollag WB (2023) Association of psoriasis and stroke in end-stage renal disease patients. Am J Med Sci 366(6):413\u2013420. https:\/\/doi.org\/10.1016\/j.amjms.2023.09.014","journal-title":"Am J Med Sci"},{"issue":"4","key":"5299_CR72","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.amjms.2022.08.003","volume":"365","author":"N Siddiquee","year":"2023","unstructured":"Siddiquee N, Waller JL, Baer SL, Mohammed A, Tran S, Siddiqui B, Padala S, Young L, Kheda M, Bollag WB (2023) Association of psoriasis with myocardial infarction in end-stage renal disease patients. Am J Med Sci 365(4):329\u2013336. https:\/\/doi.org\/10.1016\/j.amjms.2022.08.003","journal-title":"Am J Med Sci"},{"key":"5299_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20852","author":"G Zheng","year":"2025","unstructured":"Zheng G, Zhang Y, Su H, Yang H, Ma Z, Li L, Li Y, Ji C, Xia Y, Zhao Y (2025) Cardiovascular-kidney-metabolic health, genetic predisposition and incident risk of psoriasis. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.20852","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"5299_CR74","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10067-015-3126-4","volume":"35","author":"L Visconti","year":"2016","unstructured":"Visconti L, Leonardi G, Buemi M, Santoro D, Cernaro V, Ricciardi CA, Lacquaniti A, Coppolino G (2016) Kidney disease and psoriasis: novel evidences beyond old concepts. Clin Rheumatol 35(2):297\u2013302. https:\/\/doi.org\/10.1007\/s10067-015-3126-4","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5299_CR75","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12288-011-0143-6","volume":"29","author":"SK Ramamoorthy","year":"2012","unstructured":"Ramamoorthy SK, Hephziba R (2012) Acute renal failure post high dose methotrexate infusion successfully managed with high dose folinic acid and high flux dialysis. Indian J Hematol Blood Transfus 29(2):90\u201392. https:\/\/doi.org\/10.1007\/s12288-011-0143-6","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"6","key":"5299_CR76","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","volume":"82","author":"A Menter","year":"2020","unstructured":"Menter A, Gelfand JM, Connor C, Armstrong AW, Cordoro KM, Davis DMR, Elewski BE, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Prater EF, Rahimi RS, Rupani RN, Siegel M, Stoff B, Strober BE, Tapper EB, Wong EB, Wu JJ, Hariharan V, Elmets CA (2020) Joint American Academy of Dermatology\u2013National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol 82(6):1445\u20131486. https:\/\/doi.org\/10.1016\/j.jaad.2020.02.044","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"5299_CR77","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/1389200219666181031113505","volume":"20","author":"Q Wu","year":"2019","unstructured":"Wu Q, Kuca K (2019) Metabolic pathway of cyclosporine A and its correlation with nephrotoxicity. Curr Drug Metab 20(2):84\u201390. https:\/\/doi.org\/10.2174\/1389200219666181031113505","journal-title":"Curr Drug Metab"},{"issue":"3","key":"5299_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12875","volume":"32","author":"JR Hong","year":"2019","unstructured":"Hong JR, Lee YW, Choe YB, Ahn KJ (2019) Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice. Dermatol Ther 32(3):e12875. https:\/\/doi.org\/10.1111\/dth.12875","journal-title":"Dermatol Ther"},{"key":"5299_CR79","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5961","volume":"347","author":"J Wan","year":"2013","unstructured":"Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM (2013) Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ 347:f5961. https:\/\/doi.org\/10.1136\/bmj.f5961","journal-title":"BMJ"},{"issue":"1","key":"5299_CR80","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/bjd.13599","volume":"173","author":"HY Chiu","year":"2015","unstructured":"Chiu HY, Huang HL, Li CH, Yin YJ, Chen HA, Hsu ST, Lin SJ, Tsai TF, Ho SY (2015) Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. Br J Dermatol 173(1):146\u2013154. https:\/\/doi.org\/10.1111\/bjd.13599","journal-title":"Br J Dermatol"},{"issue":"5","key":"5299_CR81","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrneph.2013.44","volume":"9","author":"MGH Betjes","year":"2013","unstructured":"Betjes MGH (2013) Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol 9(5):255\u2013265. https:\/\/doi.org\/10.1038\/nrneph.2013.44","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"5299_CR82","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5021\/ad.2010.22.3.300","volume":"22","author":"WJ Choi","year":"2010","unstructured":"Choi WJ, Park EJ, Kwon IH, Kim KH, Kim KJ (2010) Association between psoriasis and cardiovascular risk factors in Korean patients. Ann Dermatol 22(3):300\u2013306. https:\/\/doi.org\/10.5021\/ad.2010.22.3.300","journal-title":"Ann Dermatol"},{"issue":"1","key":"5299_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94165-w","volume":"11","author":"SH Lee","year":"2021","unstructured":"Lee SH, Kim M, Han KD, Lee JH (2021) Low hemoglobin levels and an increased risk of psoriasis in patients with chronic kidney disease. Sci Rep 11(1):14741. https:\/\/doi.org\/10.1038\/s41598-021-94165-w","journal-title":"Sci Rep"},{"key":"5299_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030725","author":"A Gluba-Brz\u00f3zka","year":"2020","unstructured":"Gluba-Brz\u00f3zka A, Franczyk B, Olszewski R, Rysz J (2020) The influence of inflammation on anemia in CKD patients. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21030725","journal-title":"Int J Mol Sci"},{"key":"5299_CR85","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-025-01472-5","author":"A Shi","year":"2025","unstructured":"Shi A, Shu Y, Haddad JE, Wu S, Smayra K, Sudesh SM, Mourad MM, Farzad A, Yap N, Andrikopoulou E, Liu Q, Li P, Tu Y (2025) Cardiovascular and kidney outcomes after systemic treatment for plaque psoriasis: a systematic review and network meta-analysis. Dermatol Ther (Heidelb). https:\/\/doi.org\/10.1007\/s13555-025-01472-5","journal-title":"Dermatol Ther (Heidelb)"},{"key":"5299_CR86","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/164_2019_323","volume":"260","author":"J Posner","year":"2019","unstructured":"Posner J, Barrington P, Brier T, Datta-Mannan A (2019) Monoclonal antibodies: past, present and future. Handb Exp Pharmacol 260:81\u2013141. https:\/\/doi.org\/10.1007\/164_2019_323","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"5299_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15202","volume":"35","author":"G Veronesi","year":"2022","unstructured":"Veronesi G, Guglielmo A, Gardini A, Sacchelli L, Loi C, Patrizi A, Bardazzi F (2022) Biological therapy in patients with psoriasis: what we know about the effects on renal function. Dermatol Ther 35(1):e15202. https:\/\/doi.org\/10.1111\/dth.15202","journal-title":"Dermatol Ther"},{"issue":"4","key":"5299_CR88","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/1346-8138.13622","volume":"44","author":"H Saeki","year":"2017","unstructured":"Saeki H, Nakagawa H, Nakajo K, Ishii T, Morisaki Y, Aoki T, Cameron GS, Osuntokun OO (2017) Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: results from a 52-week, open-label, phase 3 study (UNCOVER-J). J Dermatol 44(4):355\u2013362. https:\/\/doi.org\/10.1111\/1346-8138.13622","journal-title":"J Dermatol"},{"key":"5299_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030654","author":"K Rodr\u00edguez-Fern\u00e1ndez","year":"2022","unstructured":"Rodr\u00edguez-Fern\u00e1ndez K, Mangas-Sanju\u00e1n V, Merino-Sanju\u00e1n M, Martorell-Calatayud A, Mateu-Puchades A, Climente-Mart\u00ed M, Gras-Colomer E (2022) Impact of pharmacokinetic and pharmacodynamic properties of monoclonal antibodies in the management of psoriasis. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14030654","journal-title":"Pharmaceutics"},{"issue":"1","key":"5299_CR90","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/hdi.13185","volume":"29","author":"X Zhu","year":"2025","unstructured":"Zhu X, Pan X, Dong Z (2025) Plaque psoriasis with renal dysfunction successfully treated with ixekizumab. Hemodial Int 29(1):126\u2013129. https:\/\/doi.org\/10.1111\/hdi.13185","journal-title":"Hemodial Int"},{"issue":"1","key":"5299_CR91","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1111\/1346-8138.15132","volume":"47","author":"M Mukai","year":"2020","unstructured":"Mukai M, Kurihara Y, Ito Y, Shintani Y, Takahashi H, Kubo A, Amagai M, Umegaki-Arao N (2020) Successful treatment with secukinumab of three psoriatic patients undergoing dialysis. J Dermatol 47(1):e26\u2013e28. https:\/\/doi.org\/10.1111\/1346-8138.15132","journal-title":"J Dermatol"},{"issue":"3","key":"5299_CR92","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s13730-019-00393-5","volume":"8","author":"M Ochi","year":"2019","unstructured":"Ochi M, Toyama T, Ando M, Sato K, Kamikawa Y, Sagara A, Kitajima S, Hara A, Iwata Y, Sakai N, Shimizu M, Furuichi K, Hamaguchi Y, Kaneko S, Wada T (2019) A case of secondary IgA nephropathy accompanied by psoriasis treated with secukinumab. CEN Case Rep 8(3):200\u2013204. https:\/\/doi.org\/10.1007\/s13730-019-00393-5","journal-title":"CEN Case Rep"},{"issue":"6","key":"5299_CR93","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/ijd.17657","volume":"64","author":"Z Fratton","year":"2025","unstructured":"Fratton Z, Balato A, Bighetti S, Bettolini L, Maione V, Calzavara-Pinton P, Buononato D, Stinco G, Errichetti E (2025) Real-world experience using bimekizumab in a patient cohort with plaque-type psoriasis and chronic kidney disease: a 48-week retrospective multicentre study. Int J Dermatol 64(6):1095\u20131097. https:\/\/doi.org\/10.1111\/ijd.17657","journal-title":"Int J Dermatol"},{"key":"5299_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082250","author":"N Bernardini","year":"2024","unstructured":"Bernardini N, Ambrosio L, Tolino E, Proietti I, Skroza N, Potenza C (2024) Successful treatment with bimekizumab of a psoriatic patient undergoing hemodialysis: a case report and review of the literature. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13082250","journal-title":"J Clin Med"},{"issue":"5","key":"5299_CR95","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00403-022-02487-0","volume":"315","author":"NC Jensen","year":"2023","unstructured":"Jensen NC, Robins J, Snyder AM, Harris R, Ferris LK, Johnson L (2023) Psoriasis in the transplant population. Arch Dermatol Res 315(5):1109\u20131128. https:\/\/doi.org\/10.1007\/s00403-022-02487-0","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"5299_CR96","doi-asserted-by":"publisher","first-page":"104","DOI":"10.12788\/cutis.0167","volume":"107","author":"I Singh","year":"2021","unstructured":"Singh I, Uy A, Kassardjian A, Armstrong AW (2021) Brodalumab in an organ transplant recipient with psoriasis. Cutis 107(2):104\u2013106. https:\/\/doi.org\/10.12788\/cutis.0167","journal-title":"Cutis"},{"issue":"5","key":"5299_CR97","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.abd.2022.11.004","volume":"98","author":"LP Meneghello","year":"2023","unstructured":"Meneghello LP, Schulz DG, Costa LPD, de Carvalho AVE (2023) Case series: psoriasis in solid organ transplant patients and immunobiological agents. An Bras Dermatol 98(5):678\u2013681. https:\/\/doi.org\/10.1016\/j.abd.2022.11.004","journal-title":"An Bras Dermatol"},{"issue":"4","key":"5299_CR98","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/09546634.2017.1373737","volume":"29","author":"R Prussick","year":"2018","unstructured":"Prussick R, Wu JJ, Armstrong AW, Siegel MP, Van Voorhees AS (2018) Psoriasis in solid organ transplant patients: best practice recommendations from The Medical Board of the National Psoriasis Foundation. J Dermatolog Treat 29(4):329\u2013333. https:\/\/doi.org\/10.1080\/09546634.2017.1373737","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"5299_CR99","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1038\/jid.2010.108","volume":"130","author":"G Adhikary","year":"2010","unstructured":"Adhikary G, Chew YC, Reece EA, Eckert RL (2010) PKC-delta and -eta, MEKK-1, MEK-6, MEK-3, and p38-delta are essential mediators of the response of normal human epidermal keratinocytes to differentiating agents. J Invest Dermatol 130(8):2017\u20132030. https:\/\/doi.org\/10.1038\/jid.2010.108","journal-title":"J Invest Dermatol"},{"issue":"4","key":"5299_CR100","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1152\/physrev.00034.2007","volume":"88","author":"SF Steinberg","year":"2008","unstructured":"Steinberg SF (2008) Structural basis of protein kinase C isoform function. Physiol Rev 88(4):1341\u20131378. https:\/\/doi.org\/10.1152\/physrev.00034.2007","journal-title":"Physiol Rev"},{"issue":"6","key":"5299_CR101","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/ki.2012.439","volume":"83","author":"S Ruiz","year":"2013","unstructured":"Ruiz S, Pergola PE, Zager RA, Vaziri ND (2013) Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int 83(6):1029\u20131041. https:\/\/doi.org\/10.1038\/ki.2012.439","journal-title":"Kidney Int"},{"issue":"1","key":"5299_CR102","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1600-065X.2012.01093.x","volume":"246","author":"MT Diaz-Meco","year":"2012","unstructured":"Diaz-Meco MT, Moscat J (2012) The atypical PKCs in inflammation: NF-\u03baB and beyond. Immunol Rev 246(1):154\u2013167. https:\/\/doi.org\/10.1111\/j.1600-065X.2012.01093.x","journal-title":"Immunol Rev"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05299-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:53:41Z","timestamp":1785509621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05299-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":102,"alternative-id":["5299"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05299-7","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"25 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}